- 5 for-profit health insurers have 43% market share
- 65% of community hospitals are part of a health system
- Less than 50% of physicians have ownership in a private practice
- Over 100 hospital systems operate a health plan
- Prescription drug spending is expected to be $610 billion by 2021
- Digital health venture funding exceeded $5.8 billion in 2017
- Vertical integration deals topped $175 billion in last 12-months
As the business of healthcare approaches 20% of America’s economy – a $5.5 trillion marketplace by 2025 – we’re seeing horizontal consolidation and vertical integration run rampant. What has unleashed this reshaping of the business of healthcare? Some point to the politicalization and ad hoc dismantling of the Affordable Care Act…replacing Obamacare with Trumpcare. Others say corporate America is finally fed-up with rising healthcare costs and declining health status indicators on the global stage. Following are five business drivers behind the healthcare transformation movement:
- Fragmentation As much as the term ‘healthcare system’ is thrown around…it’s not a system! Across every vertical, the healthcare value chain is broken. Care is uncoordinated, stakeholders are siloed, and communication across the care continuum is disjointed at best. As consolidation brings key health delivery components together – providers of care, payers of care, suppliers of care –fiefdoms will breakdown and begin to unify around the consumer.
- Scalability As many healthcare upstarts are finding out, without customers it’s a long road to growth and profitability. Operating costs represent a huge drain, not to mention challenges of low brand recognition and immature market presence that goes with a small base of existing customers. Food for thought: combine CVS’ 9800 retail outlets, 1100 clinics, 94 million PBM members, 5.5 million Medicare drug plan members with Aetna’s 38 million customers (including over 2 million drug plan members)…scale can be a beautiful thing!
- Efficiency Unsustainable administrative costs, red-tape bureaucracy, and legacy information systems will be the death knell of healthcare as we know it. Waste represents more than 20% of total healthcare expenditures in the United States. While the jury is still out on efficiency gains of consolidated health systems, mass-negotiated pharmaceutical rates, and even value or outcomes based reimbursement schemes, these are the boundaries that must be pushed.
- Dominance Driven by both a spirit of entrepreneurship and need to achieve efficiencies and scale in order to contain costs, new market dominators or ‘titans of healthcare’ will emerge, and be formidable adversaries. At risk in this ‘healthcare oligopoly’ is competition. Think about it: 90% of Americans live within 10 miles of a Walmart…now add Humana’s almost 9 million Medicare members; 75% of Americans live within 5 miles of a Walgreens…now add lab-testing partnerships with LabCorp and Quest.
- Consumerism Ahhh, lest we forget about the customer! There’s a reason why so many health care entities are hiring a Chief Experience Officer (CXO). Healthcare customer service sucks! At every step along the health care customer journey there’s friction, complexity and frustration. If there’s anything driving the healthcare industry to change it’s consumers. From Gen Y to Millennials to Boomers – they will not engage with healthcare the way it is now. They are demanding change: virtual health, telemedicine, retail clinics, wearables, and active aging.
Uncertainty and volatility will reign for the foreseeable future – count on it! While there may be a period where ‘deal-of-the-day’ dynamics die down, given the number and size of transactions in the current pipeline, absorption and integration will take time. Fallout from industry consolidation we’re seeing today will need 2-3 years to settle into a mature state. In the meantime, markets will be disrupted and competitors disintermediated.
Successful companies don’t sit still in transformative, disrupted markets – whether disrupted by consolidation or innovation. Even the most risk-adverse businesses must adapt. After looking internally and externally at where you stand today (i.e., level of readiness), identify what needs to be retooled to deal with shifting markets, new competitors and changing rules of the game. Then, create a series of scenarios or pro-formas to address business objectives (i.e., growth, profitability, product and services, operations) in this re-reconfigured landscape. Finally, select and prioritize specific, tangible opportunities; build the business case; design a structured, sequenced approach to achieve results; and, formulate an actionable, measurable go-to-market implementation plan…your roadmap to readiness. Then, go forth and win!